We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
-5.17%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$6.16B
AUM Growth
-$821M
Cap. Flow
-$392M
Cap. Flow %
-6.36%
Top 10 Hldgs %
16.27%
Holding
911
New
217
Increased
113
Reduced
100
Closed
202

Top Buys

Rank Stock Value
1
SGEN
Seagen Inc. Common Stock
SGEN
+$100M
2
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$97M
3
LRCX icon
Lam Research
LRCX
+$85.4M
4
BSX icon
Boston Scientific
BSX
+$79.4M
5
MRK icon
Merck
MRK
+$67M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$145M
2
ASML icon
ASML
ASML
+$119M
3
QRVO icon
Qorvo
QRVO
+$89M
4
MSFT icon
Microsoft
MSFT
+$82.9M
5
ISRG icon
Intuitive Surgical
ISRG
+$75.5M

Sector Composition

Rank Sector Weight
1 Healthcare 38.56%
2 Technology 29.01%
3 Industrials 8.79%
4 Communication Services 5.99%
5 Financials 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGIIW
701
DELISTED
Seaport Global Acquisition II Corp. Warrants
SGIIW
$4K ﹤0.01%
+12,500
New +$4.73K
CXAC.WS
702
DELISTED
C5 Acquisition Corporation Public warrants, each whole public warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
CXAC.WS
$4K ﹤0.01%
+12,500
New +$4.09K
VGII.WS
703
DELISTED
Virgin Group Acquisition Corp. II Redeemable Warrants, each whole warrant exercisable for one Class
VGII.WS
$4K ﹤0.01%
10,000
– –
TVGNW icon
704
Tevogen Inc. Warrant
TVGNW
$899K
$3K ﹤0.01%
+12,500
New +$4.65K
IQMDW
705
DELISTED
Intelligent Medicine Acquisition Corp. Warrant
IQMDW
$3K ﹤0.01%
+12,500
New +$4.56K
TWNI.WS
706
DELISTED
Tailwind International Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
TWNI.WS
$3K ﹤0.01%
16,666
– –
CEROW
707
DELISTED
CERo Therapeutics Warrants
CEROW
$2K ﹤0.01%
12,500
– –
SZZLW
708
DELISTED
Sizzle Acquisition Corp. Warrant
SZZLW
$2K ﹤0.01%
+12,500
New +$2.67K
APN.WS
709
DELISTED
Apeiron Capital Investment Corp. Redeemable Warrants
APN.WS
$2K ﹤0.01%
+12,500
New +$3.71K
ABBV icon
710
AbbVie
ABBV
$431B
– –
-1,070,201
Closed -$145M
ACAD icon
711
Acadia Pharmaceuticals
ACAD
$4.9B
– –
-416,200
Closed -$9.71M
ACT icon
712
Enact Holdings
ACT
$6.79B
– –
-40,000
Closed -$827K
ADSK icon
713
Autodesk
ADSK
$51.2B
– –
-75,111
Closed -$21.1M
AGEN
714
Agenus
AGEN
$312M
– –
-33,499
Closed -$2.12M
AKA icon
715
a.k.a. Brands
AKA
$118M
– –
-18,750
Closed -$2.08M
AKBA icon
716
Akebia Therapeutics
AKBA
$264M
– –
-2,231,966
Closed -$5.04M
AMCX icon
717
AMC Global Media
AMCX
$490M
– –
-100,841
Closed -$3.47M
AMD icon
718
Advanced Micro Devices
AMD
$799B
– –
-233,409
Closed -$33.6M
AME icon
719
Ametek
AME
$57.6B
– –
-190,944
Closed -$28.1M
APH icon
720
Amphenol
APH
$210B
– –
-1,494,568
Closed -$65.4M
APLS
721
DELISTED
Apellis Pharmaceuticals
APLS
– –
-41,199
Closed -$1.95M
ARBK
722
Argo Blockchain
ARBK
$41.4M
– –
-188
Closed -$492K
ASML icon
723
ASML
ASML
$655B
– –
-149,400
Closed -$119M
AVIR icon
724
Atea Pharmaceuticals
AVIR
$399M
– –
-208,399
Closed -$1.86M
AZO icon
725
AutoZone
AZO
$50.1B
– –
-6,000
Closed -$12.6M
27 28
29
30 31

Similar funds

TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM
KK
KLP Kapitalforvaltning Oslo, Norway $25.5B AUM 28.18% 1-Year Est. Return

Woodline Partners's Q1 2022 Portfolio in Review

As of Q1 2022, Woodline Partners held 911 positions worth $6.16B, down 12% from $6.98B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Woodline Partners withdrew a net $392M in Q1 2022, closing 202 positions and reducing 100 holdings. Its most notable exit was AbbVie, an estimated $145M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 41% a quarter earlier, followed by Technology and Industrials.

Against the trend, Woodline Partners opened a new position in ZYNGA INC. CL A COMMON worth $102M.

  • Woodline Partners's largest Q1 2022 buy was ZYNGA INC. CL A COMMON: 11,039,458 shares worth $102M.
  • Woodline Partners added most to Seagen Inc. Common Stock in Q1 2022, an estimated $100M increase.
  • Woodline Partners's biggest Q1 2022 reduction was Qorvo, cutting an estimated $89M.
  • Woodline Partners fully exited AbbVie in Q1 2022, selling an estimated $145M.
  • Woodline Partners's ten largest holdings make up 16% of its $6.16B portfolio in Q1 2022.
  • Woodline Partners opened 217 new positions and closed 202 in Q1 2022.
  • Woodline Partners's portfolio value fell 12% quarter-over-quarter to $6.16B.

Based on Woodline Partners's 13F filing for Q1 2022, filed 16 May 2022.